Clinical Trial Update: A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether trimethoprim alters the pharmacokinetics of the extended-release paliperidone formulation (Invega ER) in individuals with schi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega ER (paliperidone extended-release) (Paliperidone)
• TRIMETHOPRIM (TRIMETHOPRIM)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED